[Topical treatment of pigmentation disorders with cosmetic and pharmaceutical agents].

[1]  Miriam Sonnet.  Neue Therapien der Hyperpigmentierung am Horizont? , 2019, ästhetische dermatologie & kosmetologie.

[2]  S. Verma,et al.  Role of broad‐spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma , 2019, Journal of cosmetic dermatology.

[3]  R. Dabas,et al.  A Randomized Controlled Study Comparing the Efficacy of Topical 5% Tranexamic Acid Solution versus 3% Hydroquinone Cream in Melasma , 2019, Journal of cutaneous and aesthetic surgery.

[4]  Y. Boo,et al.  Human skin‐depigmenting effects of resveratryl triglycolate, a hybrid compound of resveratrol and glycolic acid , 2018, International journal of cosmetic science.

[5]  R. Halder,et al.  Are Natural Ingredients Effective in the Management of Hyperpigmentation? A Systematic Review. , 2018, The Journal of clinical and aesthetic dermatology.

[6]  T. Vogt,et al.  [Melasma : An update on the clinical picture, treatment, and prevention]. , 2017, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[7]  E. Pierzchała,et al.  Comparison of efficacy of products containing azelaic acid in melasma treatment , 2016, Journal of cosmetic dermatology.

[8]  H. Kan,et al.  Traffic-Related Air Pollution Contributes to Development of Facial Lentigines: Further Epidemiological Evidence from Caucasians and Asians. , 2016, The Journal of investigative dermatology.

[9]  A. Hüls,et al.  [Environmentally induced (extrinsic) skin aging]. , 2016, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[10]  C. Bayerl,et al.  Unerwünschte und erwünschte Pigmentierung , 2015, Der Hautarzt.

[11]  Y. Boo,et al.  A study of the human skin-whitening effects of resveratryl triacetate , 2015, Archives of Dermatological Research.

[12]  Z. Draelos.  A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone. , 2015, Journal of the American Academy of Dermatology.

[13]  N. Virmani,et al.  Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety , 2013, Indian journal of dermatology.

[14]  R. Bhat,et al.  A Comparative Study of the Efficacy of 4% Hydroquinone vs 0.75% Kojic Acid Cream in the Treatment of Facial Melasma , 2013, Indian journal of dermatology.

[15]  P. Jain,et al.  Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation. , 2013, Journal of drugs in dermatology : JDD.

[16]  B. Elewski,et al.  Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy. , 2013, Journal of drugs in dermatology : JDD.

[17]  W. Krause.  Krankheitsbild mit breitem Spektrum , 2012, hautnah dermatologie.

[18]  Jean Krutmann,et al.  Airborne particle exposure and extrinsic skin aging. , 2010, The Journal of investigative dermatology.

[19]  C. Berking,et al.  Grundlagen der Hautpigmentierung , 2010, Der Hautarzt.

[20]  S. Katiyar,et al.  Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms , 2010, Archives of Dermatological Research.

[21]  J. Krutmann.  Actives : Zentraler Bestandteil des modernen Lichtschutzes , 2009 .

[22]  G. Mujtaba,et al.  Comparison of efficacy of topical 2% liquiritin, topical 4% liquiritin and topical 4% hydroquinone in the management of melasma , 2009 .

[23]  H. Korting,et al.  Evidenz-basierte Kosmetika: Konzept und Anwendung bei den Zielstellungen Licht-geschädigte Altershaut und Xerosis , 2009, Wiener klinische Wochenschrift.

[24]  J. A. Burch,et al.  A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. , 2008, Journal of the American Academy of Dermatology.

[25]  R. Boissy,et al.  DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency , 2005, Experimental dermatology.

[26]  M. Jarratt.  Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. , 2004, Cutis.

[27]  C. Berge,et al.  Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin 1 , 2004, International journal of cosmetic science.

[28]  K. Scharffetter-Kochanek,et al.  Solar UV irradiation and dermal photoaging. , 2001, Journal of photochemistry and photobiology. B, Biology.

[29]  P. Creidi,et al.  Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. , 2001, The Journal of investigative dermatology.

[30]  J. Krutmann.  Die Verwendung von topisch applizierten DNS-Reparaturenzymen zum Schutz der menschlichen Haut gegen UVB-induzierte Schäden , 2001, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[31]  M. Metwalli,et al.  Topical liquiritin improves melasma , 2000, International journal of dermatology.

[32]  J. Bhawan,et al.  Short- and long-term histologic effects of topical tretinoin on photodamaged skin. , 1998, International journal of dermatology.

[33]  J H Epstein,et al.  Postinflammatory hyperpigmentation. , 1989, Clinics in dermatology.